Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inherited Neurodegenerative Disorders”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07561957
What this trial is testing

A Smart Phone Application to Improve Adoption of the 2024 Kidney Disease Improving Global Outcomes (KDIGO) Chronic Kidney Disease (CKD) Guidelines

Who this might be right for
Chronic Kidney DiseaseProteinuriaBlood Pressure Control+5 more
St. James's Hospital, Ireland 80
Early research (Phase 1)Study completedNCT01903681
What this trial is testing

Assessment of the Pharmacokinetics of Circadin® in Children With Neurodevelopmental Disorders and Sleep Disturbances

Who this might be right for
Sleep Problems
Neurim Pharmaceuticals Ltd. 16
Not applicableEnrolling By InvitationNCT03836300
What this trial is testing

Parent and Infant Inter(X)Action Intervention (PIXI)

Who this might be right for
Fragile X SyndromeAngelman SyndromePrader-Willi Syndrome+11 more
RTI International 120
Not applicableEnded earlyNCT02859428
What this trial is testing

Disease Natural History and Biomarkers of SPG3A, SPG4A, and SPG31

Who this might be right for
Hereditary Spastic Paraplegia
National Institute of Neurological Disorders and Stroke (NINDS) 51
Not applicableLooking for participantsNCT06716931
What this trial is testing

Investigating Exercise in Myotonic Dystrophy Type 2 (DM2)

Who this might be right for
Myotonic Dystrophy 2
Massachusetts General Hospital 24
Not applicableStudy completedNCT01838018
What this trial is testing

Brain Perfusion in Pantothenate Kinase-associated Neurodegeneration (PKAN)

Who this might be right for
Pantothenate Kinase-associated Neurodegeneration (PKAN)
Susan J. Hayflick 10
Large-scale testing (Phase 3)Study completedNCT02415127
What this trial is testing

Safety, Tolerability and Efficacy of ACTIMMUNE® Dose Escalation in Friedreich's Ataxia

Who this might be right for
Friedreich's Ataxia
Amgen 92
Testing effectiveness (Phase 2)Looking for participantsNCT06874010
What this trial is testing

A Multiple Ascending Dose Study of DT-216P2 in Patients With Friedreich's Ataxia

Who this might be right for
Friedreich Ataxia
Design Therapeutics, Inc. 20
Not applicableStudy completedNCT02479360
What this trial is testing

Reliability of Functional Outcome Measures in Neurofibromatosis 1

Who this might be right for
Neurofibromatosis 1, NF1
Guy's and St Thomas' NHS Foundation Trust 49
Large-scale testing (Phase 3)Study completedNCT03293524
What this trial is testing

Efficacy & Safety Study of Bilateral IVT Injection of GS010 in LHON Subjects Due to the ND4 Mutation for up to 1 Year

Who this might be right for
Leber Hereditary Optic Neuropathy
GenSight Biologics 98
Post-approval studies (Phase 4)Study completedNCT05864846
What this trial is testing

Investigate Behavioral and Other Co-Occurring Outcomes With Epidiolex as Add-On Therapy in Participants Aged 1 to 65 Years of Age With Tuberous Sclerosis Complex

Who this might be right for
Tuberous Sclerosis Complex Associated Neuropsychiatric Disease
Jazz Pharmaceuticals 79
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05126888
What this trial is testing

SCI-110 in the Treatment of Tourette Syndrome

Who this might be right for
Tourette Syndrome
Neurothera Labs Inc. 164
Not applicableStudy completedNCT04595578
What this trial is testing

Cerebellar rTMS and Physical Therapy for Cerebellar Ataxia

Who this might be right for
Multiple System Atrophy, Cerebellar Variant (Disorder)Spinocerebellar Ataxias
Samsung Medical Center 34
Testing effectiveness (Phase 2)Study completedNCT02967679
What this trial is testing

SERENDEM : MD1003 in Patients Suffering From Demyelinating Neuropathies, an Open Label Pilot Study

Who this might be right for
Chronic Inflammatory Demyelinating PolyneuropathyPeripheral NeuropathyCharcot-Marie-Tooth Disease+3 more
MedDay Pharmaceuticals SA 15
Not applicableActive Not RecruitingNCT06040567
What this trial is testing

Polyneuropathy, Impairments and Physical Activity - The PolyImPAct Study

Who this might be right for
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)Vasculitic NeuropathyPOEMS Syndrome+6 more
Rigshospitalet, Denmark 520
Testing effectiveness (Phase 2)Ended earlyNCT01942993
What this trial is testing

The Effects of Treatment With Vemurafenib on the Immune System in Advanced Melanoma

Who this might be right for
Melanoma
Philip Friedlander 3
Not applicableStudy completedNCT01242007
What this trial is testing

Postural Spirometry Changes in Ambulatory Myotonic Dystrophy Patients

Who this might be right for
Myotonic Dystrophy
University of Nancy 58
Large-scale testing (Phase 3)Study completedNCT01421992
What this trial is testing

Methylphenidate in Myotonic Dystrophy Type 1

Who this might be right for
Dystrophia Myotonica 1
Laval University 28
Testing effectiveness (Phase 2)Study completedNCT05882734
What this trial is testing

Tuvusertib (M1774) in Combination With Cemiplimab in Participants With Non-Squamous NSCLC (DDRiver NSCLC 322)

Who this might be right for
Non-Small Cell Lung Cancer
EMD Serono Research & Development Institute, Inc. 61
Post-approval studies (Phase 4)Active Not RecruitingNCT05044819
What this trial is testing

Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution

Who this might be right for
Lennox Gastaut SyndromeDravet SyndromeTuberous Sclerosis Complex
Jazz Pharmaceuticals 154
Next Page